Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study

Multiple Sclerosis

Volumn 22, Issue 5, 2016, Pages 685-693

  McKay, Kyla A ^a   Tremlett, Helen ^a   Fisk, John D ^b   Patten, Scott B ^c   Fiest, Kirsten ^d   Berrigan, Lindsay ^e   Marrie, Ruth Ann ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e ST FRANCIS XAVIER UNIVERSITY   (Canada)

Author keywords

anxiety; cohort; depression; health behaviour; Multiple sclerosis

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ANXIETY; ARTICLE; AWARENESS; CANADA; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIPLE SCLEROSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; SMOKING; PREVALENCE; CLINICAL TRIAL; DISABILITY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PSYCHOLOGY;

ADULT; ANXIETY; DEPRESSION; DISABILITY EVALUATION; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES;

EID: 84961692484     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515599073     Document Type: Article

References (35)

1. Feinstein A, Magalhaes S, Richard J-F, et al. The link between multiple sclerosis and depression. Nat Rev Neurol 2014; 10 (9): 507-517.
2. Wood B, van der Mei IAF, Ponsonby A-L, et al. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler 2013; 19 (2): 217-224.
3. Marrie R, Horwitz R, Cutter G, et al. High frequency of adverse health behaviors in multiple sclerosis. Mult Scler 2009; 15 (1): 105-113.
4. Jané-Llopis E, Matytsina I,. Mental health and alcohol, drugs and tobacco: A review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev 2006; 25: 515-536.
5. Quesnel S, Feinstein A,. Multiple sclerosis and alcohol: A study of problem drinking. Mult Scler 2004; 10: 197-201.
6. Beier M, D'Orio V, Spat J, et al. Alcohol and substance use in multiple sclerosis. J Neurol Sci 2014; 338: 122-127.
7. Bombardier CH, Blake KD, Ehde DM, et al. Alcohol and drug abuse among persons with multiple sclerosis. Mult Scler 2004; 10: 35-40.
8. Brown RF, Valpiani EM, Tennant CC, et al. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol Psychother 2009; 82: 41-56.
9. Sullivan EV, Pfefferbaum A,. Neurocircuitry in alcoholism: A substrate of disruption and repair. Psychopharmacology (Berl) 2005; 180: 583-594.
10. Smith KJ, Kapoor R, Hall SM, et al. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 2001; 49: 470-476.
11. Handel AE, Williamson AJ, Disanto G, et al. Smoking and multiple sclerosis: An updated meta-analysis. PLoS One 2011; 6 (1): e16149.
12. Pakpoor J, Goldacre R, Disanto G, et al. Alcohol misuse disorders and multiple sclerosis risk. JAMA Neurol 2014; 71 (9): 1088-1189.
13. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13 (3): 227-231.
14. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50 (1): 121-127.
15. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846.
16. Lublin FD, Reingold SC,. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology 1996; 46: 907-911.
17. Zigmond AS, Snaith RP., The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-70.
18. Honarmand K, Feinstein A,. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler 2009; 15 (12): 1518-1524.
19. Ewing JA,. Detecting alcoholism: The CAGE Questionnaire. J Am Med Assoc 1984; 252 (14): 1905-1907.
20. WHO. Guidelines for controlling and monitoring the tobacco epidemic. Geneva: World Health Organization; 1996.
21. Kushner MG, Abrams K, Borchardt C,. The relationship between anxiety disorders and alcohol use disorders: A review of major perspectives and findings. Clin Psychol Rev 2000; 20 (2): 149-171.
22. Bulloch A, Lavorato D, Williams J, et al. Alcohol consumption and major depression in the general population: The critical importance of dependence. Depress Anxiety 2012; 29 (November 2011): 1058-1064.
23. Kessler RC,. The epidemiology of dual diagnosis. Biol Psychiatry 2004; 56: 730-737.
24. Haukkala A, Uutela A, Vartiainen E, et al. Depression and smoking cessation: The role of motivation and self-efficacy. Addict Behav 2000; 25 (2): 311-316.
25. Taylor G, McNeill A, Girling A, et al. Change in mental health after smoking cessation: Systematic review and meta-analysis. Br Med J 2014; 348: 1-22.
26. Manouchehrinia A, Tench CR, Maxted J, et al. Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain 2013; 136: 2298-2304.
27. Agaku IT, King BA, Dube SR,. Current cigarette smoking among adults -' United States, 2005-2012. Morb Mortal Wkly Rep 2014; 63 (2): 29-46.
28. Poulin C, Webster I, Single E,. Alcohol disorders in Canada as indicated by the CAGE questionnaire. Can Med Assoc J 1997; 157 (11): 1529-1535.
29. Giannantoni A, Scivoletto G, Di Stasi SM, et al. Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. Arch Phys Med Rehabil 1999; 80: 437-441.
30. Marrie RA, Reingold S, Cohen J, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review. Mult Scler 2015; 21 (3): 305-317.
31. Gold SM, Irwin MR,. Depression and immunity: Inflammation and depressive symptoms in multiple sclerosis. Immunol Allergy Alinics North Am 2009; 29: 309-320.
32. Patten SB, Metz LM, Reimer MA,. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Mult Scler 2000; 6: 115-120.
33. Davis CG, Thake J, Vilhena N,. Social desirability biases in self-reported alcohol consumption and harms. Addict Behav 2010; 35: 302-311.
34. Fleming M, Barry K, Manwell L, et al. Brief physician advice for problem drinkers. J Am Med Assoc 1997; 278: 1059-1060.
35. Hughes J, Stead L, Cahill K, et al. Antidepressants for smoking cessation (review). Cochrane Libr 2014; (1): 1-145.